![]() High Technology News and Information for the Rocky Mountain Region |
|
Wednesday, July 2, 2008
AlloCure Raises $14.5M Salt Lake City-based AlloCure said Wednesday that the firm has raised $14.5M in a Series A financing round. The round came from SV Life Sciences, which led the round, along with Novo A/S. AlloCure is a biotechnology firm developing therapies for the treatment of acute kidney injury. The firm said the funding would go towards funding its acute kidney disease therapy through Phase II clinical trials, over the next three years. posted on Wednesday, July 2, 2008 (Link to more information)
|
Previous Issues Friday, October 10, 2008 Thursday, October 9, 2008 Wednesday, October 8, 2008 Tuesday, October 7, 2008 Monday, October 6, 2008 |